- Home
- / Eagle Genomics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Eagle Genomics financials data including stock price, CreditSafe score, income statement, balance sheet, and acquistions and subsidiaries.
Total Funding
$12.4 M
Revenue
£2.5 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|
| Revenue | 467.8K | 1.4M | 2.5M |
| Cost of goods sold | 104.1K | 221.8K | 254.2K |
| Gross profit | 363.8K | 1.2M | 2.2M |
| Gross profit margin, % | 77.8% | 83.8% | 89.6% |
| General and administrative expense | 4.4M | 4.7M | 7.1M |
| Operating expense total | 4.4M | 4.7M | 7.1M |
| EBIT | (3.6M) | (3.5M) | (4.9M) |
| EBIT margin, % | -770.6% | -252.1% | -201.8% |
| Interest income | 134.0 | ||
| Interest expense | 52.8K | 37.4K | 88.8K |
| Pre tax profit | (3.7M) | (3.5M) | (5.0M) |
| Net Income | (3.7M) | (3.5M) | (5.0M) |
Acquisitions & Subsidiaries
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |